| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/11/2004 | EP1387855A2 Codon-optimised nucleic acid coding for apoaequorin and uses thereof |
| 02/11/2004 | EP0970377B1 Diagnosis of epithelial cell abnormalities |
| 02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
| 02/11/2004 | EP0862615B1 Immunity against pasteurella haemolytica leukotoxin |
| 02/11/2004 | EP0858467B1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 02/11/2004 | EP0804482B1 Cytokines that bind the cell surface receptor hek |
| 02/11/2004 | CN1474871A Inhibitor proteins |
| 02/11/2004 | CN1474869A Novel compounds |
| 02/11/2004 | CN1474656A Improved bioactive whey protein hydrolysate |
| 02/11/2004 | CN1473932A Recombined rockfish adenylate cyclase activated polypeptide gene and its expression system, expression product, producing method and use |
| 02/11/2004 | CN1473854A Recombined IL4 antibody for treating IL4 insertion diseases |
| 02/11/2004 | CN1473853A Anti-bacteria endotoxin chicken ritellus antibody and its preparation and its use |
| 02/11/2004 | CN1473850A New human protein with mouse NIH/3T3 cell transformation improving function and its code sequence |
| 02/11/2004 | CN1473849A Novel human protein with cancer inhibiting function and its code sequence |
| 02/11/2004 | CN1473845A Polypeptide matter and its preparing method and use |
| 02/11/2004 | CN1473844A Polypeptide matter and its preparing method and use |
| 02/11/2004 | CN1137896C Vaccine for hoof-and-mouth disease and preparing method thereof |
| 02/11/2004 | CN1137726C Method of prolonged suppression of humoral immunity |
| 02/10/2004 | US6689876 Cloning and sequencing of allergens of dermatophagoides |
| 02/10/2004 | US6689871 Process for production diphtheria toxin |
| 02/10/2004 | US6689869 Labeled humanized anti-CD18 antibodies and fragments and kits comprising same |
| 02/10/2004 | US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity |
| 02/10/2004 | US6689750 Bactericide compositions prepared and obtained from microccus varians |
| 02/10/2004 | US6689611 Modified Streptomyces host cells for increased avermectin production and methods of making the same |
| 02/10/2004 | US6689601 High growth methanotropic bacterial strain |
| 02/10/2004 | US6689597 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 02/10/2004 | US6689585 GABA-B2 receptor |
| 02/10/2004 | US6689584 Transcriptional regulatory factor |
| 02/10/2004 | US6689580 Growth factor |
| 02/10/2004 | US6689570 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 02/10/2004 | US6689562 Mammalian IAP gene family, primers, probes and detection methods |
| 02/10/2004 | US6689561 Isolated cdk4i gene (cdk4i=cyclin-dependent kinase 4 inhibitor), in which deletions or polymorphisms have been shown to cause susceptibility to certain cancers; detecting deletions or polymorphisms; kits, diagnosis |
| 02/10/2004 | US6689369 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/10/2004 | US6689365 Follicle stimulating hormone, luteinizing hormone; varying ratios of lh activity as compared to fsh activity; fsh beta is linked through a linker to lh beta; the alpha subunit is downstream from both; fusion protein |
| 02/10/2004 | US6689362 Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP) |
| 02/10/2004 | US6689359 Ligands, including antibodies, showing reactivity against endocrine cells |
| 02/10/2004 | US6689355 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 02/10/2004 | CA2123430C Prohormone convertase transformed cells |
| 02/08/2004 | CA2436691A1 Preparation, characterization and quantification of active fractions that promote cell growth and recombinant-protein expression |
| 02/05/2004 | WO2004011902A2 Improved systems and methods for analysis of protein post-translational modification |
| 02/05/2004 | WO2004011656A1 Method for enhancing yield of recombinant protein production from plants |
| 02/05/2004 | WO2004011653A1 Novel peptide synthase gene |
| 02/05/2004 | WO2004011652A1 Process for producing tripeptide or higher peptide |
| 02/05/2004 | WO2004011651A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | WO2004011636A2 Method of enzymatic deubiquitination |
| 02/05/2004 | WO2004011611A2 Taci antibodies and uses thereof |
| 02/05/2004 | WO2004011609A2 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 02/05/2004 | WO2004011599A2 Polypeptide cleavage process |
| 02/05/2004 | WO2004011490A1 A immounlogical epitope of the hiv strain type o and the uses thereof |
| 02/05/2004 | WO2004011485A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | WO2004010957A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 02/05/2004 | WO2004010947A2 Humanized antibodies against human 4-1bb |
| 02/05/2004 | WO2003097871A3 Marker molecules associated with lung tumors |
| 02/05/2004 | WO2003093320A3 Antibodies specific for human cd22 and their therapeuatic and digagnostic uses |
| 02/05/2004 | WO2003089624A3 Fc receptor homolog, reagents, and uses thereof |
| 02/05/2004 | WO2003066091A3 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 02/05/2004 | WO2003059272A3 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 02/05/2004 | WO2003055911A8 Cystine-knot fold protein |
| 02/05/2004 | WO2003048390A8 A process for the preparation of a non-toxic anthrax vaccine |
| 02/05/2004 | WO2003037172A3 Endothelial-cell binding peptides for diagnosis and therapy |
| 02/05/2004 | WO2003016915A8 Tumor specific oligosaccharide sequences and use thereof |
| 02/05/2004 | WO2002072776A3 Cell culture system for synthesis of infectious hepatitis c virus |
| 02/05/2004 | US20040025199 Comprises g-protein couple receptors for identifying modulators of g-protein activity and diagnosis and treatment of infections, nervous system, tumor, autoimmune and inflammatory disorders |
| 02/05/2004 | US20040024192 19 human secreted proteins |
| 02/05/2004 | US20040024179 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 02/05/2004 | US20040023929 Small molecules for inhibition of function and drug delivery to leukocytes |
| 02/05/2004 | US20040023856 Purified DNA comprising a sequence encoding a B1k chain of laminin. Vector comprising a DNA sequence encoding a B1k protein. |
| 02/05/2004 | US20040023391 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 02/05/2004 | US20040023340 Method for producing human anti-thymocyte immunoglobulins |
| 02/05/2004 | US20040023339 Transgenic cell culture for preparing monoclonal antibodies for treatment and prevention of cancer |
| 02/05/2004 | US20040023337 IL-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/05/2004 | US20040023335 IL-17 like molecules and uses thereof |
| 02/05/2004 | US20040023334 Comprises lactoferrin fusion protein for diagnosis, prevention treatment and prognosis of nervous system, respiratory, cardiovascular and/or reproductive system disorders |
| 02/05/2004 | US20040023333 Production of recombinant blood clotting factors in human cell lines |
| 02/05/2004 | US20040023331 Comprises membrane protein for diagnosis, prevention and treatment cell proliferative disorders; tumor detection |
| 02/05/2004 | US20040023329 Preparing cells for use as bioreactors for expression of heterologous polypeptides |
| 02/05/2004 | US20040023326 Comprises inhibitory monoclonal antibody for controlling metabolic processes associated with cytochrome c oxidase/debrisoquine hydroxylase; drug screening and development; competetive binding |
| 02/05/2004 | US20040023323 Novel cytokine receptors and nucleic acids encoding the same |
| 02/05/2004 | US20040023321 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis |
| 02/05/2004 | US20040023316 Using monoclonal antibody to diagnose helicobacter infection in human waste |
| 02/05/2004 | US20040023315 Transgenic yeast cells coding membrane receptor proteins for diagnosis and treatment of pancreatitis, pancreatic cancer, gastrointestinal disorders and irritable bowel disease |
| 02/05/2004 | US20040023307 DNA encoding a novel RG1 polypeptide |
| 02/05/2004 | US20040023291 Comprises insect polypeptide for use in hemolysis and immunosuppression; immunotherapy |
| 02/05/2004 | US20040023278 Sialoadhesin family member-2 (SAF-2) |
| 02/05/2004 | US20040023271 Using oligonucleotide sequences and strand displacement amplification to determine the concentration of preferential DNA sequences in sample |
| 02/05/2004 | US20040023267 Comprises nucleotide sequences coding cancer associated proteins (CAP) for diagnosis, prevention and treatment of tumors |
| 02/05/2004 | US20040023260 29 human secreted proteins |
| 02/05/2004 | US20040023257 Comprises nucleotide sequences coding proteolytic enzymes for increasing flavor in food, promoting microbiocidal activity, modifying and deprotecting chemical intermediates, synthesis and hydrolysis of cephalosporins |
| 02/05/2004 | US20040023233 DNA sequences found in the regulatory region of cytoprotective genes that are cytoprotective response elements |
| 02/05/2004 | US20040022804 Administering protein Q or a variant thereof containing modifications or substitutions of preserved amino acid residues, protein Q or variant thereof being optionally combined with complete or fragmented protein LiHsp70 and |
| 02/05/2004 | US20040022802 Surface proteins of Leptospira |
| 02/05/2004 | US20040022801 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2004 | US20040022782 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 02/05/2004 | US20040022781 Proteins and nucleic acids encoding same |
| 02/05/2004 | US20040022772 Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth |
| 02/05/2004 | US20040022767 Novel cytokine designated elk ligand |
| 02/05/2004 | US20040022763 Human recombinant beta-interferon with improved solubility |
| 02/05/2004 | CA2802205A1 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 02/05/2004 | CA2727782A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2493798A1 Improved systems and methods for analysis of protein post-translational modification |